
Tim McCutcheon
THE TRANSFORMATION of Ovoca Bio into Talisman Metals was due to be voted through at the EGM this week. It is clear that investors have significant faith in the latest chapter for Ovoca, which looks set to considerably broaden its horizons under CEO Tim McCutcheon. Having sold its remaining interest in its failed biopharmaceutical business,… Read more »
This content is only available to Phoenix subscribers.




